Literature DB >> 8966232

Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.

S M Bentzen1, A C Ruifrok, H D Thames.   

Abstract

Early mucosal reactions are a major concern in radiotherapy of tumors in the head and neck. With some of the current strategies for altered fractionation these reactions may become dose limiting, and this has created a renewed interest in their radiobiology. The present paper reviews data on the response of mucosa in the head and neck to a change in dose per fraction (repair capacity) and time interval between dose fractions (repair kinetics). A review of clinical data on repair capacity shows that the alpha/beta ratio of the linear-quadratic model is high, around 10 Gy. Also, the steepness of the dose-response curve for mucositis is high as quantified by the maximum value of the normalized dose-response gradient, gamma 50 = 6.9 +/- 2.1. Computer simulations illustrate how this high value may be explained by the structural and proliferative organization of the mucosa. Finally, data from the following four recent studies are analyzed: the Radiation Therapy Oncology Group studies 7913 and 8313, a study from the M.D. Anderson Cancer Center, and a study from the Center of Oncology in Warsaw. All of these studies showed a decrease in the incidence of mucosal reactions when the interval between fractions given in the same day was increased, typically from around 4 h to around 6 h. It is shown that the maximum dose-equivalent of repair in the time interval between 4 h and 6 h occurs for a repair halftime of about 3.2 h. A comparison between the steepness of dose-response curves from studies not involving incomplete repair and those derived from the above four studies shows that the repair halftime for human mucosa must be relatively long, probably in the range 2 to 4 h. The statistical resolution of the available data as well as a number of caveats in the design of the studies preclude a more rigorous estimation of the repair halftime for mucosa. Although the tumor data are less conclusive, a similar repair halftime cannot be excluded for epithelial tumors in the head and neck.

Entities:  

Mesh:

Year:  1996        PMID: 8966232     DOI: 10.1016/0167-8140(95)01689-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.

Authors:  Su Berrak; Sanjeev Chawla; Sungheon Kim; Harry Quon; Eric Sherman; Laurie A Loevner; Harish Poptani
Journal:  Acad Radiol       Date:  2011-08-10       Impact factor: 3.173

2.  A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.

Authors:  Igor Shuryak; Philip Hahnfeldt; Lynn Hlatky; Rainer K Sachs; David J Brenner
Journal:  Radiat Environ Biophys       Date:  2009-06-05       Impact factor: 1.925

3.  Biphasic and monophasic repair: comparative implications for biologically equivalent dose calculations in pulsed dose rate brachytherapy of cervical carcinoma.

Authors:  W T Millar; J H Hendry; S E Davidson
Journal:  Br J Radiol       Date:  2013-08-09       Impact factor: 3.039

4.  [Risks of unfavorable cosmetic and toxicity after percutaneous accelerated partial breast irradiation (APBI). Interim analysis from the Canadian RAPID trial].

Authors:  M D Piroth
Journal:  Strahlenther Onkol       Date:  2013-12       Impact factor: 3.621

5.  [Arrhythmias].

Authors:  Lars Eckardt
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-11       Impact factor: 0.840

6.  [Concurrent once-daily or twice-daily chemoradiotherapy in limited-stage small-cell lung cancer?]

Authors:  Susanne Frosch; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2018-01       Impact factor: 3.621

7.  Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations.

Authors:  Søren M Bentzen; John R Yarnold
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-15       Impact factor: 7.038

8.  Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.

Authors:  Brian A Hrycushko; Shihong Li; Beth Goins; Randal A Otto; Ande Bao
Journal:  Med Phys       Date:  2011-03       Impact factor: 4.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.